<DOC>
	<DOCNO>NCT02498041</DOCNO>
	<brief_summary>This study evaluate diagnostic accuracy , safety acceptability transnasal endoscopy ( TNE ) diagnosis Barrett 's esophagus ( BE ) . This cross-over randomise trial , whereby patient receive two endoscopic procedure 2-4 week apart randomise receive either TNE standard endoscopy follow procedure .</brief_summary>
	<brief_title>The Efficacy Patient Tolerance Ultrathin Nasal Endoscopy Detect Barrett 's Oesophagus</brief_title>
	<detailed_description>Background : The incidence esophageal adenocarcinoma ( EAC ) drammatically increase Western World last 30 year . Furthermore often present late stage prognosis remain poor overall 5-year survival 10-15 % . Early detection possible since case EAC develop precursor condition , Barrett 's esophagus ( BE ) , via metaplasia-dysplasia-adenocarcinoma sequence . BE diagnose upper GI endoscopy . Un-sedated trans-nasal endoscopy ( TNE ) may safer less expensive standard endoscopy ( SE ) detect BE . Emerging technology require robust evaluation routine use . Objective : To evaluate sensitivity , specificity , acceptability TNE diagnose BE compare SE . Design : Prospective , randomize , crossover study Setting : Single , tertiary-care referral center . Patients : patient BE refer diagnostic assessment enrol consecutively . Intervention : All patient undergo TNE follow SE reverse . Spielberger State-Trait Anxiety Inventory , short-form questionnaire , visual analogue scale , single question address preference endoscopy type administer . Main Outcome Measurements : Diagnostic accuracy BE tolerability TNE SE . The primary aim study evaluate sensitivity specificity ultrathin endoscopy diagnose BE ( use standardise endoscopic histopathological criterion ) compare gold standard white light conventional endoscopy . The secondary aim include assess acceptability , optical quality safety two intervention . The study consist two phase . In first large phase 80 % target ( 90 patient ) evaluate conventional TNE ( Fujinon ) . In second phase remain patient ( 25 ) evaluate disposable office-based system ( Endosheath ) .</detailed_description>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<criteria>1 . Age : &gt; 18 year &lt; 75 year 2 . Patients give informed consent capable filling questionnaire . 3 . Patients require endoscopy dyspepsia followup evaluation patient prior diagnosis BE ( define minimum Barrett 's length 2cm accord M level Prague C &amp; M classification ) specialize intestinal metaplasia histological confirmation . 1 . Previous upper GI tract upper respiratory tract surgery know upper GI tract abnormality ( e.g . pharyngeal pouch ) . 2 . Coagulopathy anticoagulant 3 . Active severe cardiopulmonary disease liver disease 4 . Active GI bleeding 5 . Patients alarm symptom refer fast track service patient dysphagia 6 . Patients require possible endoscopic therapy 7 . Patients highgrade dysplasia intramucosal carcinoma BE require extensive evaluation biopsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Ultrathin Nasal Endoscopy</keyword>
	<keyword>Barrett 's Esophagus</keyword>
	<keyword>Transnasal Endoscopy</keyword>
</DOC>